Physician profile
Mark R Licht
NPI 1306841473
$4,110.82
in general payments reported to CMS, 2019-2025
29 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $180 · 2021: $457 · 2022: $850 · 2023: $1,052 · 2024: $900 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,064.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $1,487.44 | 2019-2024 | Xiaflex, Aveed, Edex |
| Boston Scientific Corporation | $437.58 | 2019-2024 | Rezum Generator, Lithovue, Ams 700 |
| Astellas Pharma US INC | $412.24 | 2019-2024 | Xtandi |
| Endo USA, INC. | $310.08 | 2024-2025 | Xiaflex, Aveed |
| Pfizer INC. | $193.38 | 2019-2025 | |
| Axonics, INC. | $149.26 | 2023-2024 | Axonics, Bulkamid |
| Allergan, INC. | $148.90 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $117.98 | 2022-2024 | Dificid |
| Abbvie INC. | $114.09 | 2022-2025 | |
| Blue Earth Diagnostics | $105.97 | 2024 | |
| Teleflex LLC | $80.85 | 2023-2024 | Urolift |
| Celgene Corporation | $78.28 | 2023 | Zeposia |
| Tolmar, INC. | $71.62 | 2023-2025 | Eligard, Jatenzo |
| Olympus America INC. | $47.40 | 2023-2024 | Itind System |
| Coloplast Corp | $43.35 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $36.07 | 2023 | Interstim, Nuro |
| Urogen Pharma, INC. | $33.01 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $29.68 | 2024 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $26.60 | 2023 | Gemtesa |
| Braintree Laboratories, INC. | $24.48 | 2023 | Sutab |
| Bayer Healthcare Pharmaceuticals INC. | $23.26 | 2019 | |
| Dendreon Pharmaceuticals LLC | $22.59 | 2019 | |
| Antares Pharma, INC. | $20.96 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.43 | 2023 | Gattex |
| Myriad Genetic Laboratories, INC. | $17.82 | 2020 | |
| Medline Industries LP | $16.69 | 2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $16.24 | 2019 | |
| Vivus LLC | $13.91 | 2022 | |
| Amgen INC. | $12.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Licht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.